The FDA recently granted CryoLife approval for a new 10 ml disposable syringe for its BioGlue Surgical Adhesive.

The BioGlue Syringe provides surgeons with "an effective adhesive in an easy-to-use, self-contained, disposable syringe, ideally suited for complex cardiovascular surgery procedures," the company says. Currently available in Europe, the 10 ml BioGlue Syringe will be introduced to the U.S. market late in the first quarter of 2006. The BioGlue Syringe is already available in the U.S. in 2 ml and 5 ml volumes.

"Extensive clinical experience continues to demonstrate BioGlue's safety and effectiveness in a range of surgical procedures benefiting patients in the U.S. and internationally," said Steven Anderson, president and CEO of CryoLife "We expect the new 10ml syringe to be a catalyst of BioGlue sales growth in the U.S."